Transfusion Treatment in Patients With SCD
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03397017 |
Recruitment Status :
Recruiting
First Posted : January 11, 2018
Last Update Posted : May 5, 2022
|
Sponsor:
Società Italiana Talassemie ed Emoglobinopatie
Collaborators:
Associazione Italiana de Ematologia e Oncologia Pediatrica
Società Italiana di Medicina Trasfusionale e Immunoematologia
Information provided by (Responsible Party):
Società Italiana Talassemie ed Emoglobinopatie
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Recruiting |
---|---|
Actual Primary Completion Date : | December 31, 2016 |
Estimated Study Completion Date : | June 30, 2022 |
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):